SCHEMBL1484013

SCHEMBL1484013

N=C(NO)c1ccc(NC(=O)CN2CCOCC2)cn1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.58
LMNA P02545 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
ALDH1A1 P00352 8/20 0.54
HPGD P15428 2/20 0.54
ALOX15 P16050 1/20 0.54
TSHR P16473 1/20 0.54
HRH3 Q9Y5N1 1/20 0.51
HTT P42858 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA9 Q16790 1/20 0.51
MEN1 O00255 1/20 0.50
POLB P06746 1/20 0.50
KMT2A Q03164 1/20 0.50
GAA P10253 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
MAPK1 P28482 1/20 0.50
MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15986841 0.78 TSHR (0.65) ATMLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL6555426 0.74 ALDH1A1 (0.80) ATMLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL1483637 0.74 HDAC1 (0.50) LMNASMN1; SMN2MEN1KMT2AGAA
SCHEMBL9921691 0.73 ATM (0.76) ATMLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL13025526 0.72 ATM (0.74) ATMLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL403057 0.72 ATM (0.74) ATMLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL3216808 0.72 ATM (0.74) ATMLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL10122851 0.71 LMNA (1.00) ATMLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL22793764 0.71 ATM (0.68) ATMLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL8338968 0.71 HRH3 (0.73) ATMLMNASMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8314103-B2 Pyridyl derivatives, their preparation and use Piramal Enterprises Limited (IN) 2012-11-20 US disclosed
US-20110077252-A1 PYRIDYL DERIVATIVES, THEIR PREPARATION AND USE Piramal Enterprises Limited (IN) 2011-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110077252-A1 PYRIDYL DERIVATIVES, THEIR PREPARATION AND USE HIF1AN, HIF1A, MTOR ATM 605/4885LMNA 1638/4885SMN1; SMN2 3664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.